Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioTelemetry Inc (NASDAQ:BEAT)

19.29
Delayed Data
As of Aug 26
 +0.17 / +0.89%
Today’s Change
8.74
Today|||52-Week Range
21.42
+65.15%
Year-to-Date
BioTelemetry, Vonage and TPI Composites Have Dipped
Aug 25 / TheStreet.com - Paid Partner Content
BioTelemetry (BEAT) Scales New 52-Week High on Solid Q2
Aug 19 / Zacks.com - Paid Partner Content
BioTelemetry Forms Partnership with Bloomlife, Stock Down
Aug 24 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close19.12
Today’s open19.13
Day’s range18.84 - 19.45
Volume478,497
Average volume (3 months)411,138
Market cap$540.6M
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+64.49%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+7.16%
P/E ratio41.0
Price/Sales1.90
Price/Book6.93

Competitors

 Today’s
change
Today’s
% change
MZORMazor Robotics Ltd-0.16-0.69%
CRYCryoLife Inc+0.34+2.22%
ATRCAtriCure Inc+0.16+1.10%
ANGOAngioDynamics Inc+0.05+0.30%
Data as of 4:02pm ET, 08/26/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.18
Annual revenue (last year)$178.5M
Annual profit (last year)$7.4M
Net profit margin4.16%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Joseph H. Capper
Chief Financial Officer &
Senior Vice President
Heather C. Getz
Corporate headquarters
Malvern, Pennsylvania

Forecasts

Partner Offers

Search for Jobs